trial · primary record
Dapagliflozin 10mg
Acute Heart Failure
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 108 |
| Primary completion | 2025-08-05 |
| Primary endpoint | Change in dyspnea VAS (Visual analogue scale) |
| Registry ID | NCT06783166 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:45.044Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06783166
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.